Anebulo Pharmaceuticals Inc(NASDAQ:ANEB) 
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing solutions for people suffering from acute cannabinoid intoxication (ACI) and substance addiction.
Website: https://www.anebulo.com/
Founded: 2020
Founder: Joseph F. Lawler
CEO: Daniel Schneeberger
Sector:
Industry:
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 1.06
H 1.07
L 1.00
C 1.02
V 37,259
10EMA 1.02
20EMA 1.02
60EMA 1.02
120EMA 1.02
250EMA 1.02